MEMasoumeh Emamghoreishi

Masoumeh Emamghoreishi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Masoumeh Emamghoreishi has a total of 114 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Dimethyl Fumarate Attenuates Behavioral and Structural Impairments Associated with Brain Ischemia in Rats

    by Mohammad Bakhtiari, Masoumeh Emamghoreishi, Maryam Khastkhodaei Ardakani, Mohammad Reza Namavar

    Introduction: Ischemic stroke remains one of the leading causes of death and physical and mental disability. Oxidative stress, free radicals, and inflammation play critical roles in ischemic brain damage. Free radical scavengers such as edaravone and dimethyl fumarate (DMF), known for their antioxidant and anti-inflammatory properties, are considered promising targets for ischemic stroke treatment. This study aimed to assess the impact of these drugs on brain ischemia Methods: Forty-nine rats were randomly divided into seven groups: sham, edaravone, and DMF controls, as well as edaravone, DMF 5, 15, and 30 groups. Middle cerebral artery occlusion (MCAO) was induced in all groups except the sham group. The MCAO groups were administered with either the vehicle, edaravone (3 mg/kg), or DMF at doses of 5, 15, and 30 mg/kg twice daily for 14 days. Neurobehavioral assessments were conducted throughout the experiment, and anatomical changes in the brain were evaluated using stereological methods. Results: Edaravone and three doses of DMF improved neurobehavioral functions. All treated rats showed a reduction in the ischemic volume and cell loss in the brain regions when compared with the control animals. MCAO reduced the total number of neurons and just DMF doses had a significant effect on this factor. Interestingly, MCAO increased the number of non-neurons and only the DMF 30 group significantly decreased this parameter. DMF 30 was more effective in ischemic stroke. Conclusions: Although edaravone improved neurological functions and reduced the size of brain ischemia and cell loss, DMF, especially at higher doses, exerted a more beneficial effect on these parameters. Therefore, DMF could be proposed as a reinforcement to currently conventional therapies.

  • Open Access

    COMPARISON OF THE EFFECT OF SALVIA OFFICINALIS EXTRACT AND VITEX AGNUS-CASTUS EXTRACT ON ANXIETY IN POSTMENOPAUSAL WOMEN: A RANDOMIZED, TRIPLE-BLIND, PLACEBO-CONTROLLED TRIAL

    by Afsaneh Zeidabadi, Masoumeh Emamghoreishi, Naeimeh Tayebi, Marzieh Akbarzadeh

    Background: This study aimed to determine the effect of Salvia officinalis extract and Vitex agnus-castus extract on anxiety in postmenopausal women. Methods: This study was a triple-blind randomized controlled clinical trial on 99 eligible postmenopausal women in Shiraz, Iran. Sampling was done using at the beginning convenience sampling from among women referring to the clinic of Namazi Hospital in Shiraz, Iran, and then permuted block randomization was used to assign patients into three groups in a 1:1:1 ratio, who were divided into 3 groups (2 intervention groups and 1 control group). Data collection tools were a demographic questionnaire and the Spielberger's State-Trait Anxiety Inventory (STAI) questionnaire. The first intervention group received Agnogel tablets (3.2-1.8 mg) once daily, the second group received Salvigol tablets (100 mg) and the third group received placebo (100 mg starch) 3 times a day for 12 weeks. STAI was again completed by the subjects after 3 months. Data were analyzed by SPSS-18 using ANOVA and paired t-test at a significance level of 0.05. Results: Mean anxiety scores before and after the intervention were 83.3 ± 24.3 and 27.5 ± 12.7 in the Agnogol group; 84.1 ± 27.8 and 26.8 ± 7.4 in the Salvigol group; and 86.3 ± 32.1 and 34.8 ± 14.1 in the control group, respectively. Based on the results of paired t-test, the decrease in mean anxiety scores in the Salvigol and Agnogel groups were significant (P< 0.001).Conclusion: The present study showed that Salvia officinalis extract and Vitex agnus-castus extract may have a good effect on relieving anxiety, so they can be used as a low-cost method with no side effects to reduce anxiety and hypochondriasis in postmenopausal women.


  • Morphological changes in the substantia nigra pars reticulata of the mice during kindling

    by M.S. Shahpari, M.R.N. Namavar, L.K.D. Kamali Dolatabadi, H.A. Aligholi, M.E. Emamghoreishi

  • Open Access

    The Effect of Spironolactone on β-amyloid-Induced Memory Impairment in Male Rats: The Role of Microglial Inhibition

    by Mohammad Mehdipour, Masoumeh Emamghoreishi, Majid Reza Farrokhi, Elahe Amirinezhadfard, Mojtaba Keshavarz

    Purpose: Neuroinflammation was indicated in the pathophysiology of Alzheimer’s disease(AD). Previous reports have also signified that spironolactone has anti-inflammatory effects.Therefore, the aim of this study was to assess the modulatory effects of spironolactone onneuroinflammation and memory loss in a rat model of AD.Methods: The β-amyloid protein fragment 25-35 (Aβ) was injected in the dorsal hippocampus (5μg/2.5 μL each side) of male Sprague-Dawley rats for four consecutive days to induce memoryimpairment. Animals have intraperitoneally received spironolactone (10, 25, or 50 mg/kg, N = 6/group) or vehicle for 14 days. The passive inhibitory avoidance and the novel recognition testswere used for memory evaluation. Neuroinflammation was assessed by measuring the level ofIba1 protein, a marker of microglial activation, using western immunoblotting.Results: Different doses of spironolactone showed no significant changes in latency times anddiscriminations ratios in passive inhibitory avoidance and novel recognition tests, respectively,as compared to vehicle. However, spironolactone-treated groups showed significantly lowerIba1 protein levels in comparison to the vehicle-treated group (P < 0.01).Conclusion: Spironolactone had a modulatory effect on neuroinflammation through a repressiveeffect on microglial activation with no valuable effect on memory improvement in a rat modelof AD. The findings of this study suggest that Aβ-induced memory loss may not be directly linkedto microglial activation. Spironolactone may be a potential candidate to be examined in otherneuroinflammatory disorders.


  • Open Access

    The Impact of Salvia officinalis Extract on Depression in Postmenopausal Women: A Randomized Clinical Trial

    by Naeimeh Tayebi, Masoumeh Emamghoreishi, Marzieh Akbarzadeh

    Objectives: This study aimed to investigate the impact of the Salvia officinalis extract on the depression of postmenopausal women referred to the bone density measurement center in Shiraz. Materials and Methods: In this controlled randomized tria1, 60 postmenopausal women were randomly divided into a control group and an intervention group. The participants were allocated to two groups of S. officinalis and placebo using random permuted blocks with a block size of 6. After 3 months, depression was measured by Edinburgh Postnatal Depression Scale (EPDS) in both groups. Then, the independent t test was used to analyze the obtained data in SPSS version 21.0. Results: Based on the results, the control and intervention groups were homogeneous in terms of the level of education, occupation, and housing, and the decrease in mean depression scores in the Salvigol group was significant (P<0.001). Conclusions: Salvia officinalis extract has antidepressant properties. As the rate of depression increases during menopause, it is recommended to be used as a supplement.


  • Open Access

    Effect of Vitex agnus-castus on Depression of Postmenopausal Women: A Randomized Clinical Trial

    by Naeimeh Tayebi, Masoumeh Emamghoreishi, Marzieh Akbarzadeh

    Background: During menopause, women undergo biological, social, and psychological changes and are sensitive to stressors, especially anxiety and depression. Decreased estrogen in postmenopausal women causes mood swings, especially depression and anxiety. Objectives: We aimed to determine the effect of the Vitex agnus-castus extract on depression in postmenopausal women referring to a bone density measurement center in Shiraz. Methods: In a randomized controlled tria1, 60 postmenopausal women were randomly divided into an intervention group and a control group. In the intervention group, the research units were assigned to two groups of Vitex agnus-castus tablets and placebo, using random permuted blocks with a block size from one to six for each eligible case. After three months, depression was evaluated by the Edinburg Postnatal Depression Scale (EPDS) in both groups. Then, the results were analyzed using the independent t-test for quantitative variables. The obtained data were analyzed by a statistician using SPSS21. Results: Based on the results, the two groups were homogeneous in terms of the level of education, occupation, and housing, and a significant decrease was observed in the mean depression score in the Agnugolgroup (P < 0.001). Conclusions: Because depression increases during menopause, it is recommended that it should be used as a supplement during menopause.


  • Insulin-Like Growth Factor 2 (IGF-2) Regulates Neuronal Density and IGF-2 Distribution Following Hippocampal Intracerebral Hemorrhage

    by Farzaneh Vafaee, Asadollah Zarifkar, Masoumeh Emamghoreishi, Mohammad Reza Namavar, Shima Shirzad, Hamed Ghazavi, Vahid Mahdavizadeh


  • Open Access

    Curcumin Effects on Memory Impairment and Restoration of Irregular Neuronal Distribution in the Hippocampal CA1 Region After Global Cerebral Ischemia in Male Rats

    by Leila Kamali Dolatabadi, Masoumeh Emamghoreishi, Mohammad Reza Namavar, Hamze Badeli Sarkala

    Introduction: Global Cerebral Ischemia (GCI) causes neuronal damage with subsequent neurological and cognitive impairments. Curcumin has anti-inflammatory, antioxidant, and neuroprotective properties, which makes it a potential candidate for improving GCI-induced impairments. This study aimed to investigate the effects of curcumin on the neurological and memory deficits, as well as spatial neuronal ...


  • Open Access

    Antidepressant Effects of the Aqueous and Hydroalcoholic Extracts of Salvia mirzayanii and Salvia macrosiphon in Male Mice

    by Parisa Sarkoohi, Mohammad Fathalipour, Fatemeh Ghasemi, Katayoun Javidnia, Masoumeh Emamghoreishi

    As some species of the Salvia family have been shown to exert antidepressant-like activity, the aim of this study was to investigate the antidepressant effects of the aqueous and hydroalcoholic extracts of Salvia mirzayanii and Salvia macrosiphon, two endemic species of salvia in Iran.In total, 148 eight-week-old male albino mice (25 - 35 g) were used to carry out the forced swimming test. The effects of different doses of the aqueous (100 - 1800 mg/kg) and hydroalcoholic extracts (75 - 900 mg/kg) of Salvia mirzayanii and Salvia macrosiphon on immobility, climbing, and swimming behaviors were examined. Fluoxetine and imipramine were used as control drugs. The effects of extracts on locomotor activity were also evaluated.High doses of the aqueous extracts of both plants and hydroalcoholic extract of Salvia mirzayanii produced a significant reduction in immobility and increase in swimming compared to the control group. The hydroalcoholic extract of Salvia macrosiphon did not show any significant effect on immobility and swimming. Only some doses of hydroalcoholic extract of Salvia mirzayanii and aqueous extract of Salvia macrosiphon showed a significant increase in climbing behavior. The aqueous and hydroalcoholic extract of both plants caused a decrease in spontaneous activity.The findings of this study indicated that the aqueous and hydroalcoholic extracts of Salvia mirzayanii and the aqueous extract of Salvia macrosiphon had antidepressant-like activity. In addition, the hydroalcoholic extract of Salvia mirzayanii and the aqueous extracts of Salvia macrosiphon were more effective fractions of these plants. These endemic Iranian Salvia species may have potential therapeutic effects for depression.


  • Open Access

    Validity and Reliability of the Persian Versions of National Institute of Health Stroke Scale and Modified National Institute of Health Stroke Scale in Hospitalized Patients

    by Reza Dehghani, Afshin Borhanihaghighi, Abdolhamid Shariat, Mohammad Nami, Masoume Nazeri, Amin Abolhasani Foroughi, Samrad Mehrabi, Masoumeh Emamghoreishi

    Background: National Institute of Health Stroke Scale (NIHSS) and Modified National Institute of Health Stroke Scale (mNIHSS) are two valid and reliable questionnaires that assess stroke severity. This study aimed to examine and compare the validity and reliability of Persian versions of NIHSS and mNIHSS in hospitalized patients. Materials and Methods: The English versions of NIHSS and mNIHSS were translated to Persian (forward and backward), and three neurologists examined the face and content validity of both questionnaires. The Persian versions of NIHSS and mNIHSS were used in75 hospitalized stroke patients (hemorrhagic and obstructive) admitted to Namazi teaching hospital, Shiraz, Iran.The reliability and validity of the Persian versions were examined by Cronbach's alpha coefficient and convergent validity. Result: The values of Cronbach's alpha for Persian versions of NIHSS and mNIHSS were 0.81 and 0.86, respectively. The scaling success of convergent validity in NIHSS and mNIHSS were 80% and 100%, respectively. Conclusion: The Persian versions of NIHSS and mNIHSS were reliable and valid. However, mNIHSS was more valid and reliable than NIHSS. Persian version of mNIHSS can be suggested to be used for assessing stroke severity in hospitalized stroke patients by neurologists and researchers. [GMJ. 2019;8:e1188]